Elotuzumab-based combination therapy for multiple myeloma relapsed after autologous transplantation

Hisao Nagoshi

Presentation information

Poster Session

Sat. Oct, 13

Poster Session 2-26 MM: Others (2)

Sat. Oct 13, 2018 5:30 PM - 6:10 PM Poster2 (Osaka International Convention Center, 5F Main Foyer)

Chair: Kyoko Yoshihara (Division of Hemotology Hyogo College of Medicine)

[PS2-26-5] Elotuzumab-based combination therapy for multiple myeloma relapsed after autologous transplantation

Hisao Nagoshi¹, Jun Imagawa^1,2, Keichiro Mihara¹, Keita Fujino¹, Taro Edahiro¹, Kayo Toishigawa¹, Takahiko Miyama¹, Takehiko Morioka¹, Takakazu Kawase³, Noriyasu Fukushima³, Tatsuo Ichinohe³ (1.Hematol., Hiroshima Univ. Hosp., Hiroshima, Japan, 2.Hematol., Higashihiroshima Med. Center, Hiroshima, Japan, 3.Hematol./Oncol., RIRBM, Hiroshima Univ., Hiroshima, Japan)

Abstract password authentication.
Password is written on a program and abstract book.